Company: PSTV
Filing Date: 2025-04-30
Form Type: 10-K/A
Source: 0000950170-25-061028
Chunk: 8

Company: PLUS THERAPEUTICS, INC.
Filing Date: 2025-04-30
Form: 10-K/A
Chunk 8
---
-Johansson received a M.D. from Erasmus University, Rotterdam, The Netherlands. We believe Dr. van Es-Johansson’s qualifications to serve on our Board include her extensive medical knowledge and experience in the pharmaceutical industry. Executive Officers; Directors The following table shows information about our current executive officers and directors including their ages as of April 18, 2025:

| Name                          | Age |    |     | Position(s)                                     |
| Executive Officers            |     |    |     |                                                 |
| Marc H. Hedrick, M.D.         |     | 63 |     | President, Chief Executive Officer and Director |
| Andrew Sims                   |     | 52 |     | Chief Financial Officer                         |
| Non-Employee Directors        |     |    |     |                                                 |
| Howard Clowes(1)(2)(3)        |     | 71 |     | Director                                        |
| An van Es-Johansson, MD(1)(3) |     | 65 |     | Director                                        |
| Richard J. Hawkins            |     | 76 |     | Chairman of the Board                           |
| Robert Lenk, PhD(3)           |     | 77 |     | Director                                        |
| Kyle Guse(1)(2)               |     | 61 |     | Director                                        |

(1) Member of the audit committee. (2) Member of the compensation committee.

Member of the governance and nominating committee.

The following presents biographical information for each of our executive officers listed in the table above, other than Dr. Hedrick whose information is presented above.

Andrew Sims.Mr. Sims joined us as Chief Financial Officer in February 2020. Prior to his appointment as our Chief Financial Officer, Mr. Sims held roles at several private equity-backed companies. Between 2012 and 2017, Mr. Sims was Chief Financial Officer of Amplify LLC, an advisory and management consulting services firm. Following his time at Amplify, Mr. Sims served as Chief Financial Officer of Verbatim Support Services LLC, a litigation support company, from 2017 to 2019. His focus has been on mergers and acquisitions, integrations, corporate capitalization and building out and managing teams to support global growth. Previously, Mr. Sims was Partner at Mazars, a global accounting, advisory, audit, tax and consulting firm. Working from both the Oxford, England and New York offices, Mr. Sims audited and advised global public clients, including a variety